Similarly, a recent study has implicated the role of MAGEA3 in hepatocellular carcinoma (HCC) and suggested as a novel therapeutic avenue of targeting MAGEA3 for HCC [49]. The gene discussed is MAGEA3; the disease is hepatocellular carcinoma.